Register entry

Nanjing Xingyin Pharmaceutical Group Co. Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Labeller names
2
Live patents
0
Countries
1
Base
China
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Nanjing Xingyin Pharmaceutical Group Co. Ltd.No. 28, Jichang Road, Lishui, Nanjing, Jiangsu 211200, China (CHN)Active ingredient (API) manufacture3011942686547163139
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 bulk ingredient. By marketing category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 2, BULK INGREDIENT 1.

Dosage formNDCs
powder3
RouteNDCs
Labeller name on the listingNDCs
nanjing xingyin pharmaceutical group co. ltd.2
nanjing xingyin pharmaceutical group co.,ltd1
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
-Degarelix Acetatepowder70155-022BULK INGREDIENT
-Liraglutidepowder70155-003BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-sermorelin acetatepowder70155-608BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Neighbours

Registered in the same town

9
Compare

Comparable companies in China

Enquiry

Common questions

Is Nanjing Xingyin Pharmaceutical Group Co. Ltd. FDA approved?
Nanjing Xingyin Pharmaceutical Group Co. Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Nanjing Xingyin Pharmaceutical Group Co. Ltd.'s drugs manufactured?
The FDA register lists Nanjing. Registered operations: active ingredient (API) manufacture.
What drugs does Nanjing Xingyin Pharmaceutical Group Co. Ltd. make?
3 products are listed under Nanjing Xingyin Pharmaceutical Group Co. Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.